The First European Conference on Infections in Leukaemia – ECIL1: A current perspective-Reference-Cited by-同舟云学术

The First European Conference on Infections in Leukaemia – ECIL1: A current perspective

Published:2008-10 Issue:15 Volume:44 Page:2112-2117
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Meunier Françoise,Lukan Colette

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference12 articles.

1. Guidelines from the first European conference on infections in leukaemia: ECIL1;Cordonnier;Eur J Cancer Suppl,2007

2. European Organisation for Research and Treatment of Cancer Infectious Diseases Group. New guidelines for the management of bacterial, fungal and viral infections: ECIL-2. Available from: http://www.eortc.be/services/unit/idg/.

3. Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients;Dykewicz;Clin Infect Dis,2001

4. Quinolone prophylaxis for bacterial infections in afebrile high risk neutropenic patients;Bucaneve;Eur J Cancer Suppl,2007

5. The need for aminoglycosides in combination with Beta-lactams for high-risk, febrile neutropaenic patients with leukaemia;Drgona;Eur J Cancer Suppl,2007

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation;The Lancet Oncology;2021-06

2. Synergistic effects of Iranian seaweed compounds for anticandidal properties and optimization by Response Surface Methodology;IRAN J FISH SCI;2020

3. Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT;Health Technology Assessment;2019-11

4. Changing epidemiology of bloodstream infection in a 25-years hematopoietic stem cell transplant program: current challenges and pitfalls on empiric antibiotic treatment impacting outcomes;Bone Marrow Transplantation;2019-09-30

5. G-CSF-primed haplo-identical HSCT with intensive immunosuppressive and myelosuppressive treatments does not increase the risk of pre-engraftment bloodstream infection: a multicenter case–control study;European Journal of Clinical Microbiology & Infectious Diseases;2019-01-26